11β Hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle

Summary Objective  No data exist regarding the distribution and oxoreductase enzyme activity of 11β hydroxysteroid dehydrogenase type 1 (11β HSD‐1) in fresh human skeletal muscle. We aimed to investigate the mRNA and protein expression of 11β HSD‐1 in fresh skeletal muscle, confirm its biological ac...

Full description

Saved in:
Bibliographic Details
Published inClinical endocrinology (Oxford) Vol. 65; no. 6; pp. 800 - 805
Main Authors Jang, Christina, Obeyesekere, Varuni R., Dilley, Rodney J., Alford, Frank P., Inder, Warrick J.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.12.2006
Blackwell
Subjects
Online AccessGet full text
ISSN0300-0664
1365-2265
DOI10.1111/j.1365-2265.2006.02669.x

Cover

Abstract Summary Objective  No data exist regarding the distribution and oxoreductase enzyme activity of 11β hydroxysteroid dehydrogenase type 1 (11β HSD‐1) in fresh human skeletal muscle. We aimed to investigate the mRNA and protein expression of 11β HSD‐1 in fresh skeletal muscle, confirm its biological activity and determine its relationship with hexose‐6‐phosphate dehydrogenase (H6PDH). We also examined the muscle fibre localization of 11β HSD‐1. Design  Eleven non‐diabetic community volunteers underwent muscle biopsy of vastus lateralis. Measurements  (i) 11β HSD‐1 and H6PDH mRNA expression by quantitative reverse transcription polymerase chain reaction (RT‐PCR); (ii) protein localization and fibre type specificity by immunohistochemistry; and (iii) enzyme oxoreductase activity by percentage conversion of 3H cortisone to cortisol. Results  11β HSD‐1 mRNA was expressed at low levels compared to human liver. Mean ΔCT of skeletal muscle in 11 subjects was 19·57 (range 18·40–20·79) compared to ΔCT of 12·75 in human liver, which equates to an approximate 100‐fold higher level of expression. H6PDH mRNA was also detected with a mean ΔCT of 14·46 (range 13·13–16·60), approximately 35‐fold more abundant than 11β HSD‐1 in skeletal muscle. There was a significant correlation between 11β HSD‐1 and H6PDH (r = 0·67, P = 0·03). 11β HSD‐1 immunostaining was present in all muscle specimens, with similar distribution among fast and slow twitch fibres. 11β HSD‐1 oxoreductase activity was demonstrated, with mean conversion of cortisone to cortisol of 17·7% per 200 mg of muscle per 24 h (range 7·1–29·5%). Conclusions  11β HSD‐1 mRNA and protein is expressed in fresh human skeletal muscle along with readily demonstrable oxoreductase activity. 11β HSD‐1 localization is not muscle fibre type specific. High levels of skeletal muscle H6PDH should ensure that oxoreductase activity predominates in vivo.
AbstractList Summary Objective  No data exist regarding the distribution and oxoreductase enzyme activity of 11β hydroxysteroid dehydrogenase type 1 (11β HSD‐1) in fresh human skeletal muscle. We aimed to investigate the mRNA and protein expression of 11β HSD‐1 in fresh skeletal muscle, confirm its biological activity and determine its relationship with hexose‐6‐phosphate dehydrogenase (H6PDH). We also examined the muscle fibre localization of 11β HSD‐1. Design  Eleven non‐diabetic community volunteers underwent muscle biopsy of vastus lateralis. Measurements  (i) 11β HSD‐1 and H6PDH mRNA expression by quantitative reverse transcription polymerase chain reaction (RT‐PCR); (ii) protein localization and fibre type specificity by immunohistochemistry; and (iii) enzyme oxoreductase activity by percentage conversion of 3H cortisone to cortisol. Results  11β HSD‐1 mRNA was expressed at low levels compared to human liver. Mean ΔCT of skeletal muscle in 11 subjects was 19·57 (range 18·40–20·79) compared to ΔCT of 12·75 in human liver, which equates to an approximate 100‐fold higher level of expression. H6PDH mRNA was also detected with a mean ΔCT of 14·46 (range 13·13–16·60), approximately 35‐fold more abundant than 11β HSD‐1 in skeletal muscle. There was a significant correlation between 11β HSD‐1 and H6PDH (r = 0·67, P = 0·03). 11β HSD‐1 immunostaining was present in all muscle specimens, with similar distribution among fast and slow twitch fibres. 11β HSD‐1 oxoreductase activity was demonstrated, with mean conversion of cortisone to cortisol of 17·7% per 200 mg of muscle per 24 h (range 7·1–29·5%). Conclusions  11β HSD‐1 mRNA and protein is expressed in fresh human skeletal muscle along with readily demonstrable oxoreductase activity. 11β HSD‐1 localization is not muscle fibre type specific. High levels of skeletal muscle H6PDH should ensure that oxoreductase activity predominates in vivo.
Objective  No data exist regarding the distribution and oxoreductase enzyme activity of 11β hydroxysteroid dehydrogenase type 1 (11β HSD‐1) in fresh human skeletal muscle. We aimed to investigate the mRNA and protein expression of 11β HSD‐1 in fresh skeletal muscle, confirm its biological activity and determine its relationship with hexose‐6‐phosphate dehydrogenase (H6PDH). We also examined the muscle fibre localization of 11β HSD‐1. Design  Eleven non‐diabetic community volunteers underwent muscle biopsy of vastus lateralis. Measurements  (i) 11β HSD‐1 and H6PDH mRNA expression by quantitative reverse transcription polymerase chain reaction (RT‐PCR); (ii) protein localization and fibre type specificity by immunohistochemistry; and (iii) enzyme oxoreductase activity by percentage conversion of 3 H cortisone to cortisol. Results  11β HSD‐1 mRNA was expressed at low levels compared to human liver. Mean ΔC T of skeletal muscle in 11 subjects was 19·57 (range 18·40–20·79) compared to ΔC T of 12·75 in human liver, which equates to an approximate 100‐fold higher level of expression. H6PDH mRNA was also detected with a mean ΔC T of 14·46 (range 13·13–16·60), approximately 35‐fold more abundant than 11β HSD‐1 in skeletal muscle. There was a significant correlation between 11β HSD‐1 and H6PDH ( r  = 0·67, P  = 0·03). 11β HSD‐1 immunostaining was present in all muscle specimens, with similar distribution among fast and slow twitch fibres. 11β HSD‐1 oxoreductase activity was demonstrated, with mean conversion of cortisone to cortisol of 17·7% per 200 mg of muscle per 24 h (range 7·1–29·5%). Conclusions  11β HSD‐1 mRNA and protein is expressed in fresh human skeletal muscle along with readily demonstrable oxoreductase activity. 11β HSD‐1 localization is not muscle fibre type specific. High levels of skeletal muscle H6PDH should ensure that oxoreductase activity predominates in vivo .
Author Obeyesekere, Varuni R.
Jang, Christina
Inder, Warrick J.
Alford, Frank P.
Dilley, Rodney J.
Author_xml – sequence: 1
  givenname: Christina
  surname: Jang
  fullname: Jang, Christina
  organization: Department of Endocrinology and Diabetes, St Vincent's Hospital, Melbourne, Victoria, Australia, and
– sequence: 2
  givenname: Varuni R.
  surname: Obeyesekere
  fullname: Obeyesekere, Varuni R.
  organization: Department of Endocrinology and Diabetes, St Vincent's Hospital, Melbourne, Victoria, Australia, and
– sequence: 3
  givenname: Rodney J.
  surname: Dilley
  fullname: Dilley, Rodney J.
  organization: Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia
– sequence: 4
  givenname: Frank P.
  surname: Alford
  fullname: Alford, Frank P.
  organization: Department of Endocrinology and Diabetes, St Vincent's Hospital, Melbourne, Victoria, Australia, and
– sequence: 5
  givenname: Warrick J.
  surname: Inder
  fullname: Inder, Warrick J.
  organization: Department of Endocrinology and Diabetes, St Vincent's Hospital, Melbourne, Victoria, Australia, and
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18294333$$DView record in Pascal Francis
BookMark eNqNkc9u1DAQxi1UJLYL7-ALxwQ7Tuz4ABJa-oeqLQcqcbRm7UnrrTdZ2Skkb9Nn6CPwADwTCVvtgQvMZazP_n1jfXNMjtquRUIoZzmf6t0m50JWWVHIKi8YkzkrpNT58IIsDhdHZMEEYxmTsnxFjlPaMMaqmqkF2XD-64mejy52w5h6jJ131OHdLNxiCwlpP-7w5yOnPlEcdhFTQkehdbOw9l3obr2FEEYKtvffkfqW3j1soaXpHgP2EOj2IdmAr8nLBkLCN899SW5OT25W59nll7PPq4-XmS201JmSJVOuRGANAiLophFizUu9dqoQoq6Rcy0njSmltGtcg1jDWlpuoRJSLMnbve0O0vSvJkJrfTK76LcQR8PrQpdiqiX5sH9nY5dSxMZY30Pvu7aP4IPhzMwBm42ZczRzjmYO2PwJ2AyTQf2XwWHGv9H3e_SHDzj-N2dWJ9fzaeKzPe-nlQ0HHuK9kUqoyny7PjPVhb76dHH61SjxG4_fp1Y
CODEN CLECAP
CitedBy_id crossref_primary_10_2337_db11_1345
crossref_primary_10_1002_path_4806
crossref_primary_10_1186_1868_7083_4_24
crossref_primary_10_1007_s11102_008_0098_2
crossref_primary_10_1016_j_mce_2010_12_004
crossref_primary_10_1016_j_mce_2013_03_003
crossref_primary_10_1210_jc_2006_2729
crossref_primary_10_1002_glia_21007
crossref_primary_10_1080_13813450701531219
crossref_primary_10_1002_dmrr_944
crossref_primary_10_1016_j_jsbmb_2008_06_015
crossref_primary_10_1371_journal_pone_0084057
crossref_primary_10_1210_en_2008_1618
crossref_primary_10_1007_s00125_014_3228_6
crossref_primary_10_1111_j_1365_2265_2009_03683_x
crossref_primary_10_1016_j_mce_2009_09_024
crossref_primary_10_1016_j_steroids_2011_06_003
crossref_primary_10_1210_en_2010_0957
crossref_primary_10_1210_endrev_bnae008
crossref_primary_10_2337_db09_0525
crossref_primary_10_1016_j_jsbmb_2017_07_030
crossref_primary_10_1210_en_2007_0597
crossref_primary_10_1016_j_cbi_2017_02_018
Cites_doi 10.1210/jcem-73-2-326
10.1016/S0021-9258(18)55351-5
10.1111/j.1365-2362.2005.01552.x
10.1016/j.febslet.2004.06.065
10.2337/diacare.21.12.2191
10.1210/jc.87.3.1205
10.1016/S0140-6736(96)11222-8
10.1152/ajpendo.1995.268.3.E453
10.1007/BF03343855
10.1007/s00253-002-1191-5
10.1210/er.2003-0031
10.1677/jme.1.01718
10.1007/s001250051457
10.1172/JCI111938
10.1210/jc.83.5.1668
10.1002/mus.880030308
10.1111/j.1464-5491.2005.01566.x
10.2337/diabetes.50.6.1324
10.1210/jc.2002-030017
10.1074/jbc.M404159200
10.1007/s00125-004-1407-6
10.1016/0303-7207(94)90176-7
10.1210/en.142.4.1644
10.1136/bjsm.37.5.436
10.1210/endo.142.4.8114
10.1210/jc.86.5.2296
10.2337/diabetes.51.4.1066
ContentType Journal Article
Copyright 2007 INIST-CNRS
Copyright_xml – notice: 2007 INIST-CNRS
DBID BSCLL
AAYXX
CITATION
IQODW
DOI 10.1111/j.1365-2265.2006.02669.x
DatabaseName Istex
CrossRef
Pascal-Francis
DatabaseTitle CrossRef
DatabaseTitleList
CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2265
EndPage 805
ExternalDocumentID 18294333
10_1111_j_1365_2265_2006_02669_x
CEN2669
ark_67375_WNG_5J9MDJFS_7
Genre article
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
08P
0R~
10A
1OB
1OC
29B
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAKAS
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AAQQT
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
AEFGJ
AEGXH
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHEFC
AHMBA
AIACR
AIAGR
AIDQK
AIDYY
AIQQE
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
EMOBN
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MJL
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
REN
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
X7M
XG1
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAHHS
ACCFJ
ADZOD
AEEZP
AEQDE
AEUQT
AFPWT
AIWBW
AJBDE
ESX
WRC
WUP
AAYXX
CITATION
IQODW
ID FETCH-LOGICAL-c2969-76407d4ea0feaeea9ff33b149bd723388e1196f3307779dfdfee8ab6c1ca5363
IEDL.DBID DR2
ISSN 0300-0664
IngestDate Mon Jul 21 09:14:48 EDT 2025
Wed Oct 01 02:16:29 EDT 2025
Thu Apr 24 23:01:46 EDT 2025
Wed Jan 22 16:28:40 EST 2025
Sun Sep 21 06:18:05 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Human
Oxidoreductases
Striated muscle
Enzyme
Endocrinology
11β-Hydroxysteroid dehydrogenase
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2969-76407d4ea0feaeea9ff33b149bd723388e1196f3307779dfdfee8ab6c1ca5363
Notes ark:/67375/WNG-5J9MDJFS-7
ArticleID:CEN2669
istex:68DAD6E5884568141E49BDC06AE46767E1732C36
PageCount 6
ParticipantIDs pascalfrancis_primary_18294333
crossref_citationtrail_10_1111_j_1365_2265_2006_02669_x
crossref_primary_10_1111_j_1365_2265_2006_02669_x
wiley_primary_10_1111_j_1365_2265_2006_02669_x_CEN2669
istex_primary_ark_67375_WNG_5J9MDJFS_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2006
PublicationDateYYYYMMDD 2006-12-01
PublicationDate_xml – month: 12
  year: 2006
  text: December 2006
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
PublicationTitle Clinical endocrinology (Oxford)
PublicationYear 2006
Publisher Blackwell Publishing Ltd
Blackwell
Publisher_xml – name: Blackwell Publishing Ltd
– name: Blackwell
References Tomlinson, J.W., Walker, E.A., Bujalska, I.J., Draper, N., Lavery, G.G., Cooper, M.S., Hewison, M. & Stewart, P.M. (2004) 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocrine Reviews, 25, 831-866.
Levy, J.C., Matthews, D.R. & Hermans, M.P. (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care, 21, 2191-2192.
Glanemann, C., Loos, A., Gorret, N., Willis, L.B., O'Brien, X.M., Lessard, P.A. & Sinskey, A.J. (2003) Disparity between changes in mRNA abundance and enzyme activity in Corynebacterium glutamicum: implications for DNA microarray analysis. Applied Microbiology and Biotechnology, 61, 61-68.
Zierath, J.R. & Hawley, J.A. (2004) Skeletal muscle fiber type: influence on contractile and metabolic properties. Public Library of Science Biology, 2, e348.
Gaster, M., Staehr, P., Beck-Nielsen, H., Schroder, H.D. & Handberg, A. (2001) GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes, 50, 1324-1329.
Abe, T., Kearns, C.F. & Fukunaga, T. (2003) Sex differences in whole body skeletal muscle mass measured by magnetic resonance imaging and its distribution in young Japanese adults. British Journal of Sports Medicine, 37, 436-440.
Albiston, A.L., Obeyesekere, V.R., Smith, R.E. & Krozowski, Z.S. (1994) Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Molecular and Cellular Endocrinology, 105, R11-R17.
Mabuchi, K. & Sreter, F.A. (1980) Actomyosin ATPase. II. Fiber typing by histochemical ATPase reaction. Muscle and Nerve, 3, 233-239.
Pachucki, J., Ambroziak, M., Tanski, Z., Luczak, J., Nauman, J. & Nauman, A. (2001) Type I 5′-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma. Journal of Endocrinological Investigation, 24, 253-261.
Seckl, J.R. & Walker, B.R. (2001) Minireview: 11beta-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology, 142, 1371-1376.
Bujalska, I.J., Kumar, S. & Stewart, P.M. (1997) Does central obesity reflect 'Cushing's disease of the omentum'? Lancet, 349, 1210-1213.
Zierath, J.R., Krook, A. & Wallberg-Henriksson, H. (2000) Insulin action and insulin resistance in human skeletal muscle. Diabetologia, 43, 821-835.
Nair, S., Lee, Y.H., Lindsay, R.S., Walker, B.R., Tataranni, P.A., Bogardus, C., Baier, L.J. & Permana, P.A. (2004) 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle. Diabetologia, 47, 1088-1095.
Bujalska, I.J., Draper, N., Michailidou, Z., Tomlinson, J.W., White, P.C., Chapman, K.E., Walker, E.A. & Stewart, P.M. (2005) Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1. Journal of Molecular Endocrinology, 34, 675-684.
DeFronzo, R.A., Gunnarsson, R., Bjorkman, O., Olsson, M. & Wahren, J. (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. Journal of Clinical Investigation, 76, 149-155.
Abdallah, B.M., Beck-Nielsen, H. & Gaster, M. (2005) Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes. European Journal of Clinical Investigation, 35, 627-634.
Tannin, G.M., Agarwal, A.K., Monder, C., New, M.I. & White, P.C. (1991) The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. Journal of Biological Chemistry, 266, 16653-16658.
Hickey, M.S., Carey, J.O., Azevedo, J.L., Houmard, J.A., Pories, W.J., Israel, R.G. & Dohm, G.L. (1995) Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. American Journal of Physiology, 268, E453-E457.
Bujalska, I.J., Walker, E.A., Hewison, M. & Stewart, P.M. (2002) A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. Journal of Clinical Endocrinology and Metabolism, 87, 1205-1210.
Atanasov, A.G., Nashev, L.G., Schweizer, R.A., Frick, C. & Odermatt, A. (2004) Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Letters, 571, 129-133.
Hammami, M.M. & Siiteri, P.K. (1991) Regulation of 11 beta-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. Journal of Clinical Endocrinology and Metabolism, 73, 326-334.
Christopher, M., Hew, F.L., Oakley, M., Rantzau, C. & Alford, F. (1998) Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. Journal of Clinical Endocrinology and Metabolism, 83, 1668-1681.
Whorwood, C.B., Donovan, S.J., Wood, P.J. & Phillips, D.I. (2001) Regulation of glucocorticoid receptor alpha and beta isoforms and type I, 11beta-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance? Journal of Clinical Endocrinology and Metabolism, 86, 2296-2308.
Banhegyi, G., Benedetti, A., Fulceri, R. & Senesi, S. (2004) Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum. Journal of Biological Chemistry, 279, 27017-27021.
Schinner, S., Scherbaum, W.A., Bornstein, S.R. & Barthel, A. (2005) Molecular mechanisms of insulin resistance. Diabetes Medicine, 22, 674-682.
Whorwood, C.B., Donovan, S.J., Flanagan, D., Phillips, D.I. & Byrne, C.D. (2002) Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes, 51, 1066-1075.
Brereton, P.S., Van Driel, R.R., Suhaimi, F., Koyama, K., Dilley, R. & Krozowski, Z. (2001) Light and electron microscopy localization of the 11beta-hydroxysteroid dehydrogenase type I enzyme in the rat. Endocrinology, 142, 1644-1651.
Lindsay, R.S., Wake, D.J., Nair, S., Bunt, J., Livingstone, D.E., Permana, P.A., Tataranni, P.A. & Walker, B.R. (2003) Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. Journal of Clinical Endocrinology and Metabolism, 88, 2738-2744.
2001; 50
2001; 142
2002; 51
2004; 25
2000; 43
2004; 47
1991; 73
2003; 37
2004; 2
1998; 83
1998; 21
2001; 24
2005; 22
2001; 86
2004; 571
1994; 105
1997; 349
1991; 266
2004; 279
2002; 87
1980; 3
1995; 268
2003; 61
1985; 76
2005; 34
2005; 35
2003; 88
Zierath J.R. (e_1_2_6_12_2) 2004; 2
e_1_2_6_18_2
e_1_2_6_19_2
e_1_2_6_13_2
e_1_2_6_10_2
Tannin G.M. (e_1_2_6_2_2) 1991; 266
e_1_2_6_11_2
e_1_2_6_16_2
e_1_2_6_17_2
e_1_2_6_14_2
e_1_2_6_15_2
e_1_2_6_20_2
e_1_2_6_8_2
e_1_2_6_7_2
e_1_2_6_9_2
e_1_2_6_29_2
e_1_2_6_4_2
e_1_2_6_6_2
e_1_2_6_5_2
e_1_2_6_24_2
e_1_2_6_23_2
e_1_2_6_22_2
e_1_2_6_21_2
e_1_2_6_28_2
e_1_2_6_27_2
Seckl J.R. (e_1_2_6_3_2) 2001; 142
e_1_2_6_26_2
e_1_2_6_25_2
References_xml – reference: Whorwood, C.B., Donovan, S.J., Flanagan, D., Phillips, D.I. & Byrne, C.D. (2002) Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes, 51, 1066-1075.
– reference: Levy, J.C., Matthews, D.R. & Hermans, M.P. (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care, 21, 2191-2192.
– reference: Bujalska, I.J., Draper, N., Michailidou, Z., Tomlinson, J.W., White, P.C., Chapman, K.E., Walker, E.A. & Stewart, P.M. (2005) Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1. Journal of Molecular Endocrinology, 34, 675-684.
– reference: Tannin, G.M., Agarwal, A.K., Monder, C., New, M.I. & White, P.C. (1991) The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. Journal of Biological Chemistry, 266, 16653-16658.
– reference: Gaster, M., Staehr, P., Beck-Nielsen, H., Schroder, H.D. & Handberg, A. (2001) GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes, 50, 1324-1329.
– reference: Mabuchi, K. & Sreter, F.A. (1980) Actomyosin ATPase. II. Fiber typing by histochemical ATPase reaction. Muscle and Nerve, 3, 233-239.
– reference: Schinner, S., Scherbaum, W.A., Bornstein, S.R. & Barthel, A. (2005) Molecular mechanisms of insulin resistance. Diabetes Medicine, 22, 674-682.
– reference: Hickey, M.S., Carey, J.O., Azevedo, J.L., Houmard, J.A., Pories, W.J., Israel, R.G. & Dohm, G.L. (1995) Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. American Journal of Physiology, 268, E453-E457.
– reference: Bujalska, I.J., Walker, E.A., Hewison, M. & Stewart, P.M. (2002) A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. Journal of Clinical Endocrinology and Metabolism, 87, 1205-1210.
– reference: DeFronzo, R.A., Gunnarsson, R., Bjorkman, O., Olsson, M. & Wahren, J. (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. Journal of Clinical Investigation, 76, 149-155.
– reference: Tomlinson, J.W., Walker, E.A., Bujalska, I.J., Draper, N., Lavery, G.G., Cooper, M.S., Hewison, M. & Stewart, P.M. (2004) 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocrine Reviews, 25, 831-866.
– reference: Brereton, P.S., Van Driel, R.R., Suhaimi, F., Koyama, K., Dilley, R. & Krozowski, Z. (2001) Light and electron microscopy localization of the 11beta-hydroxysteroid dehydrogenase type I enzyme in the rat. Endocrinology, 142, 1644-1651.
– reference: Pachucki, J., Ambroziak, M., Tanski, Z., Luczak, J., Nauman, J. & Nauman, A. (2001) Type I 5′-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma. Journal of Endocrinological Investigation, 24, 253-261.
– reference: Bujalska, I.J., Kumar, S. & Stewart, P.M. (1997) Does central obesity reflect 'Cushing's disease of the omentum'? Lancet, 349, 1210-1213.
– reference: Glanemann, C., Loos, A., Gorret, N., Willis, L.B., O'Brien, X.M., Lessard, P.A. & Sinskey, A.J. (2003) Disparity between changes in mRNA abundance and enzyme activity in Corynebacterium glutamicum: implications for DNA microarray analysis. Applied Microbiology and Biotechnology, 61, 61-68.
– reference: Christopher, M., Hew, F.L., Oakley, M., Rantzau, C. & Alford, F. (1998) Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. Journal of Clinical Endocrinology and Metabolism, 83, 1668-1681.
– reference: Lindsay, R.S., Wake, D.J., Nair, S., Bunt, J., Livingstone, D.E., Permana, P.A., Tataranni, P.A. & Walker, B.R. (2003) Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. Journal of Clinical Endocrinology and Metabolism, 88, 2738-2744.
– reference: Zierath, J.R., Krook, A. & Wallberg-Henriksson, H. (2000) Insulin action and insulin resistance in human skeletal muscle. Diabetologia, 43, 821-835.
– reference: Hammami, M.M. & Siiteri, P.K. (1991) Regulation of 11 beta-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. Journal of Clinical Endocrinology and Metabolism, 73, 326-334.
– reference: Whorwood, C.B., Donovan, S.J., Wood, P.J. & Phillips, D.I. (2001) Regulation of glucocorticoid receptor alpha and beta isoforms and type I, 11beta-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance? Journal of Clinical Endocrinology and Metabolism, 86, 2296-2308.
– reference: Banhegyi, G., Benedetti, A., Fulceri, R. & Senesi, S. (2004) Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum. Journal of Biological Chemistry, 279, 27017-27021.
– reference: Nair, S., Lee, Y.H., Lindsay, R.S., Walker, B.R., Tataranni, P.A., Bogardus, C., Baier, L.J. & Permana, P.A. (2004) 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle. Diabetologia, 47, 1088-1095.
– reference: Zierath, J.R. & Hawley, J.A. (2004) Skeletal muscle fiber type: influence on contractile and metabolic properties. Public Library of Science Biology, 2, e348.
– reference: Atanasov, A.G., Nashev, L.G., Schweizer, R.A., Frick, C. & Odermatt, A. (2004) Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Letters, 571, 129-133.
– reference: Seckl, J.R. & Walker, B.R. (2001) Minireview: 11beta-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology, 142, 1371-1376.
– reference: Abe, T., Kearns, C.F. & Fukunaga, T. (2003) Sex differences in whole body skeletal muscle mass measured by magnetic resonance imaging and its distribution in young Japanese adults. British Journal of Sports Medicine, 37, 436-440.
– reference: Albiston, A.L., Obeyesekere, V.R., Smith, R.E. & Krozowski, Z.S. (1994) Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Molecular and Cellular Endocrinology, 105, R11-R17.
– reference: Abdallah, B.M., Beck-Nielsen, H. & Gaster, M. (2005) Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes. European Journal of Clinical Investigation, 35, 627-634.
– volume: 24
  start-page: 253
  year: 2001
  end-page: 261
  article-title: Type I 5′‐iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma
  publication-title: Journal of Endocrinological Investigation
– volume: 142
  start-page: 1644
  year: 2001
  end-page: 1651
  article-title: Light and electron microscopy localization of the 11beta‐hydroxysteroid dehydrogenase type I enzyme in the rat
  publication-title: Endocrinology
– volume: 21
  start-page: 2191
  year: 1998
  end-page: 2192
  article-title: Correct homeostasis model assessment (HOMA) evaluation uses the computer program
  publication-title: Diabetes Care
– volume: 51
  start-page: 1066
  year: 2002
  end-page: 1075
  article-title: Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome
  publication-title: Diabetes
– volume: 268
  start-page: E453
  year: 1995
  end-page: E457
  article-title: Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans
  publication-title: American Journal of Physiology
– volume: 37
  start-page: 436
  year: 2003
  end-page: 440
  article-title: Sex differences in whole body skeletal muscle mass measured by magnetic resonance imaging and its distribution in young Japanese adults
  publication-title: British Journal of Sports Medicine
– volume: 279
  start-page: 27017
  year: 2004
  end-page: 27021
  article-title: Cooperativity between 11beta‐hydroxysteroid dehydrogenase type 1 and hexose‐6‐phosphate dehydrogenase in the lumen of the endoplasmic reticulum
  publication-title: Journal of Biological Chemistry
– volume: 88
  start-page: 2738
  year: 2003
  end-page: 2744
  article-title: Subcutaneous adipose 11 beta‐hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians
  publication-title: Journal of Clinical Endocrinology and Metabolism
– volume: 105
  start-page: R11
  year: 1994
  end-page: R17
  article-title: Cloning and tissue distribution of the human 11 beta‐hydroxysteroid dehydrogenase type 2 enzyme
  publication-title: Molecular and Cellular Endocrinology
– volume: 25
  start-page: 831
  year: 2004
  end-page: 866
  article-title: 11beta‐hydroxysteroid dehydrogenase type 1: a tissue‐specific regulator of glucocorticoid response
  publication-title: Endocrine Reviews
– volume: 50
  start-page: 1324
  year: 2001
  end-page: 1329
  article-title: GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease?
  publication-title: Diabetes
– volume: 86
  start-page: 2296
  year: 2001
  end-page: 2308
  article-title: Regulation of glucocorticoid receptor alpha and beta isoforms and type I, 11beta‐hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance?
  publication-title: Journal of Clinical Endocrinology and Metabolism
– volume: 34
  start-page: 675
  year: 2005
  end-page: 684
  article-title: Hexose‐6‐phosphate dehydrogenase confers oxo‐reductase activity upon 11 beta‐hydroxysteroid dehydrogenase type 1
  publication-title: Journal of Molecular Endocrinology
– volume: 349
  start-page: 1210
  year: 1997
  end-page: 1213
  article-title: Does central obesity reflect ‘Cushing's disease of the omentum’?
  publication-title: Lancet
– volume: 2
  start-page: e348
  year: 2004
  article-title: Skeletal muscle fiber type: influence on contractile and metabolic properties
  publication-title: Public Library of Science Biology
– volume: 266
  start-page: 16653
  year: 1991
  end-page: 16658
  article-title: The human gene for 11 beta‐hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization
  publication-title: Journal of Biological Chemistry
– volume: 35
  start-page: 627
  year: 2005
  end-page: 634
  article-title: Increased expression of 11beta‐hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes
  publication-title: European Journal of Clinical Investigation
– volume: 3
  start-page: 233
  year: 1980
  end-page: 239
  article-title: Actomyosin ATPase. II. Fiber typing by histochemical ATPase reaction
  publication-title: Muscle and Nerve
– volume: 83
  start-page: 1668
  year: 1998
  end-page: 1681
  article-title: Defects of insulin action and skeletal muscle glucose metabolism in growth hormone‐deficient adults persist after 24 months of recombinant human growth hormone therapy
  publication-title: Journal of Clinical Endocrinology and Metabolism
– volume: 87
  start-page: 1205
  year: 2002
  end-page: 1210
  article-title: A switch in dehydrogenase to reductase activity of 11 beta‐hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells
  publication-title: Journal of Clinical Endocrinology and Metabolism
– volume: 142
  start-page: 1371
  year: 2001
  end-page: 1376
  article-title: – a tissue‐specific amplifier of glucocorticoid action
  publication-title: Endocrinology
– volume: 76
  start-page: 149
  year: 1985
  end-page: 155
  article-title: Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin‐dependent (type II) diabetes mellitus
  publication-title: Journal of Clinical Investigation
– volume: 47
  start-page: 1088
  year: 2004
  end-page: 1095
  article-title: 11beta‐Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle
  publication-title: Diabetologia
– volume: 73
  start-page: 326
  year: 1991
  end-page: 334
  article-title: Regulation of 11 beta‐hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action
  publication-title: Journal of Clinical Endocrinology and Metabolism
– volume: 22
  start-page: 674
  year: 2005
  end-page: 682
  article-title: Molecular mechanisms of insulin resistance
  publication-title: Diabetes Medicine
– volume: 61
  start-page: 61
  year: 2003
  end-page: 68
  article-title: Disparity between changes in mRNA abundance and enzyme activity in : implications for DNA microarray analysis
  publication-title: Applied Microbiology and Biotechnology
– volume: 571
  start-page: 129
  year: 2004
  end-page: 133
  article-title: Hexose‐6‐phosphate dehydrogenase determines the reaction direction of 11beta‐hydroxysteroid dehydrogenase type 1 as an oxoreductase
  publication-title: FEBS Letters
– volume: 43
  start-page: 821
  year: 2000
  end-page: 835
  article-title: Insulin action and insulin resistance in human skeletal muscle
  publication-title: Diabetologia
– ident: e_1_2_6_28_2
  doi: 10.1210/jcem-73-2-326
– volume: 266
  start-page: 16653
  year: 1991
  ident: e_1_2_6_2_2
  article-title: The human gene for 11 beta‐hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization
  publication-title: Journal of Biological Chemistry
  doi: 10.1016/S0021-9258(18)55351-5
– ident: e_1_2_6_21_2
  doi: 10.1111/j.1365-2362.2005.01552.x
– ident: e_1_2_6_11_2
  doi: 10.1016/j.febslet.2004.06.065
– ident: e_1_2_6_15_2
  doi: 10.2337/diacare.21.12.2191
– ident: e_1_2_6_27_2
  doi: 10.1210/jc.87.3.1205
– volume: 2
  start-page: e348
  year: 2004
  ident: e_1_2_6_12_2
  article-title: Skeletal muscle fiber type: influence on contractile and metabolic properties
  publication-title: Public Library of Science Biology
– ident: e_1_2_6_5_2
  doi: 10.1016/S0140-6736(96)11222-8
– ident: e_1_2_6_13_2
  doi: 10.1152/ajpendo.1995.268.3.E453
– ident: e_1_2_6_26_2
  doi: 10.1007/BF03343855
– ident: e_1_2_6_25_2
  doi: 10.1007/s00253-002-1191-5
– ident: e_1_2_6_4_2
  doi: 10.1210/er.2003-0031
– ident: e_1_2_6_23_2
  doi: 10.1677/jme.1.01718
– ident: e_1_2_6_6_2
  doi: 10.1007/s001250051457
– ident: e_1_2_6_29_2
  doi: 10.1172/JCI111938
– ident: e_1_2_6_16_2
  doi: 10.1210/jc.83.5.1668
– ident: e_1_2_6_19_2
  doi: 10.1002/mus.880030308
– ident: e_1_2_6_7_2
  doi: 10.1111/j.1464-5491.2005.01566.x
– ident: e_1_2_6_14_2
  doi: 10.2337/diabetes.50.6.1324
– ident: e_1_2_6_24_2
  doi: 10.1210/jc.2002-030017
– ident: e_1_2_6_10_2
  doi: 10.1074/jbc.M404159200
– ident: e_1_2_6_20_2
  doi: 10.1007/s00125-004-1407-6
– ident: e_1_2_6_17_2
  doi: 10.1016/0303-7207(94)90176-7
– ident: e_1_2_6_18_2
  doi: 10.1210/en.142.4.1644
– ident: e_1_2_6_22_2
  doi: 10.1136/bjsm.37.5.436
– volume: 142
  start-page: 1371
  year: 2001
  ident: e_1_2_6_3_2
  article-title: – a tissue‐specific amplifier of glucocorticoid action
  publication-title: Endocrinology
  doi: 10.1210/endo.142.4.8114
– ident: e_1_2_6_9_2
  doi: 10.1210/jc.86.5.2296
– ident: e_1_2_6_8_2
  doi: 10.2337/diabetes.51.4.1066
SSID ssj0005807
Score 1.9580817
Snippet Summary Objective  No data exist regarding the distribution and oxoreductase enzyme activity of 11β hydroxysteroid dehydrogenase type 1 (11β HSD‐1) in fresh...
Objective  No data exist regarding the distribution and oxoreductase enzyme activity of 11β hydroxysteroid dehydrogenase type 1 (11β HSD‐1) in fresh human...
SourceID pascalfrancis
crossref
wiley
istex
SourceType Index Database
Enrichment Source
Publisher
StartPage 800
SubjectTerms Biological and medical sciences
Endocrinopathies
Fundamental and applied biological sciences. Psychology
Medical sciences
Vertebrates: endocrinology
Title 11β Hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle
URI https://api.istex.fr/ark:/67375/WNG-5J9MDJFS-7/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-2265.2006.02669.x
Volume 65
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 0300-0664
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1365-2265
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0005807
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR3LThsx0EIgoV4Kpa0aXvIB9bZR9mWvjygkjSIlB0pVbpa9ttU0sCA2kQJfwzfwCXwA38SMdwks4oCq3lZezXo9nvHMeF6EHLDcYsyiCozK0iCJlQ2yPBZB5jJQ5YTW2md4j8Zs8CsZnqandfwT5sJU9SGWF27IGf68RgZXumwyuY_Qilha-xRA1og26pPwwltXx8-VpNI6czrGRGrGkmZQz5sfakiqNUT6AiMnVQnIc1XXi6ZG60VSf4NMnxZTRaJM2_OZbuc3r-o8_p_VbpKPteZKDytS-0RWbLFF1ke1b_4z-RuGD3d0cG3wd7D8wsXEUGP_4ABQKUhLive997chnZTULnwErjVUFQYHqmpQSDJn11T5U5hOCup7CNJyCtIRzAR6Pi9h8i_kpN876Q6CupNDkEeCiYCju9AkVnWcVdYq4VwcazDOtOERGMmZDeEkgLEO51wYZ5y1mdIsD3OVwmZ-JavFRWG_EZqk8B0HWifjYDgaBgYunCgOlBaHLvS8RfjTpsm8rnKOzTbO5AtrBzApEZPYg5NJj0m5aJFwCXlZVfp4B8x3TxdLAHU1xUg5nsrf4x8yHYrR0bD_U_IW2W8QzvMMWSSSOI5bhPntf_fUstsb49P2vwLukA9R3YSpE-6S1dnV3O6BgjXT-551HgFETRb0
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR3LbhMxcIRaCbjwRk0pxQfEbaPsetdeH6u2IYQmBwiiN8u7tkVIukVNIqV8Dd_AJ_ABfBMz3m3KIg4V4rayZHs9nqfnBfBSlI5iFk1kTZ5FKTcuykuuotznqMqpoihChvdoLAYf0uFpdtq0A6JcmLo-xObBjSgj8GsicHqQblN5CNFKRNY4FVDYqC4qlNupQLOFNKR317WksiZ3mlMqtRBpO6znryu1ZNU2gX1NsZNmgeDzdd-Ltk4bhFL_PsyvjlPHosy6q2XRLb_-UenxP533AdxrlFd2UGPbQ7jlqkdwe9S45x_D5zj--Z0NLi39D1VgOJ9aZt0nGkBERYHJ6Mn3x7eYTRfMrUMQrrPMVJYG6oJQhDXzS2YCI2bTioU2gmwxQwGJlgI7Wy1w8ycw6R9PDgdR08whKhMlVCTJY2hTZ3reGeeM8p7zAu2zwsoE7eTcxcgMcKwnpVTWW-9cbgpRxqXJuOBPYas6r9wOsDTDdTwqnkKi7WgF2rjIVDzqLZ686GUH5NWt6bIpdE79Nub6N4MHIakJktSGU-gASb3uQLyZ-aUu9nGDOa8CYmwmmIsZBcvJTH8cv9bZUI2Ohv33WnZgv4U51zvkiUo55x0Q4f5vvLU-PB7T1-6_TnwBdwaT0Yk-eTN--wzuJk1Ppl68B1vLi5V7jvrWstgPdPQLzWQbFQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR3bbtMw1EKbNPECjIEol80PiLdUTRzb8SNa13XdWqExxN4sJ7ZFacmmtZU6voZv4BP4gH3TznGybkE8TBNvkSXb8fG5-twIeS8KhzGLJrIm41HKjIuygqko8xmocirP85DhPRyJ_pd0cMpP63ZAmAtT1YdYPbghZQR-jQTuzq1vUnkI0UoEr50KIGxUGxTK9ZSrDOP7use3taR4nTvNMJVaiLQZ1vPPlRqyah3BvsTYSTMD8Pmq70VTpw1CqfeUTG-OU8WiTNqLed4ufv5V6fE_nfcZeVIrr_RjhW2b5JErn5ONYe2e3yLf4_jqN-1fWvwfrMBwNrbUum84AIgKApPik--fXzEdz6hbhiBcZ6kpLQ5UBaEQa6aX1ARGTMclDW0E6WwCAhIsBfpjMYPNX5CT3t7Jbj-qmzlERaKEiiR6DG3qTMc745xR3jOWg32WW5mAnZy5GJgBjHWklMp6653LTC6KuDCcCfaSrJVnpXtFaMphHQ-Kp5BgO1oBNi4wFQ96i0cvetEi8ubWdFEXOsd-G1N9x-ABSGqEJLbhFDpAUi9bJF7NPK-KfdxjzoeAGKsJ5mKCwXKS66-jfc0Hatgd9D5r2SLbDcy53SFLVMoYaxER7v_eW-vdvRF-vX7oxB2y8anb00cHo8M35HFSt2TqxG_J2vxi4d6BujXPtwMZXQNO6RqZ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=11%CE%B2+Hydroxysteroid+dehydrogenase+type%C2%A01+is+expressed+and+is+biologically+active+in+human+skeletal+muscle&rft.jtitle=Clinical+endocrinology+%28Oxford%29&rft.au=Jang%2C+Christina&rft.au=Obeyesekere%2C+Varuni+R.&rft.au=Dilley%2C+Rodney+J.&rft.au=Alford%2C+Frank+P.&rft.date=2006-12-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0300-0664&rft.eissn=1365-2265&rft.volume=65&rft.issue=6&rft.spage=800&rft.epage=805&rft_id=info:doi/10.1111%2Fj.1365-2265.2006.02669.x&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_5J9MDJFS_7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-0664&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-0664&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-0664&client=summon